XML 88 R60.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Information - Reportable Segment Information (Detail) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Net sales:    
Net sales $ 1,347,317 $ 1,297,402
Segment profit:    
Operating profit 196,222 163,870
Restructuring and other charges, net (4,918) (16,174)
(Losses) gains on sale of assets (754) 188
Interest expense (32,140) (36,572)
Other income (expense) (10,574) 7,278
Income before taxes 153,508 134,576
Taste    
Net sales:    
Net sales 830,322 804,802
Scent    
Net sales:    
Net sales 516,995 492,600
Corporate and Other    
Segment profit:    
Operational improvement initiative costs 0 (406)
Restructuring and other charges, net (4,918) (16,174)
(Losses) gains on sale of assets (754) 188
Frutarom Acquisition Related Costs (813) (9,529)
FDA Mandated Product Recall (649) 0
Operating Segments | Taste    
Net sales:    
Net sales 830,322 804,802
Segment profit:    
Operating profit 137,347 131,402
Operating Segments | Scent    
Net sales:    
Net sales 516,995 492,600
Segment profit:    
Operating profit 105,395 89,953
Corporate, Non-Segment    
Segment profit:    
Operating profit (20,393) (16,667)
Nutrition & Biosciences, Inc | Corporate and Other    
Segment profit:    
Integration-related costs (10,144) 0
Transaction related costs (5,199) 0
Frutarom | Corporate and Other    
Segment profit:    
Integration-related costs $ (3,650) $ (14,897)